BridgeBio Oncology Therapeutics, Inc. (BBOT)

NGM – Real Time Price. Currency in USD

9.42

+0.22 (2.39%)

At close: Aug 12, 2026, 4:00 PM EDT

9.42

0.00 (0.00%)

After-hours: Aug 12, 2026, 4:10 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-610K

-208K

Gross Profit

-610K

-208K

Operating expenses (excl. COGS)

-145M

-81M

-42K

-4K

Operating Income

-146M

-81M

-42K

-4K

Non-operating income, total

12M

Pretax income

-134M

-74M

-42K

-4K

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-134M

-74M

-42K

-4K

Discontinued operations

Net income

-134M

-74M

-42K

-4K

Dilution adjustment

Preferred dividends

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Income Statement (Annual)

Income Statement (Annual)